This paper deeply studies the intelligent Home embedded system based on B/S architecture. Firstly, analysis requirement of Home function based on the existing software development mode, and proposed a system framework...This paper deeply studies the intelligent Home embedded system based on B/S architecture. Firstly, analysis requirement of Home function based on the existing software development mode, and proposed a system framework of intelligent Home system, and designed the communication scheme of the whole Home system, also gives the system each function module realization. This paper achieve two basic service system based on Intelligent Home through a series of analysis and design： outdoor remote intelligent Home monitoring service and the indoor intelligent management service.展开更多
Hepatitis C virus(HCV)and hepatitis B virus(HBV)infections are increasingly recognized as significant etiological factors in the pathogenesis of B-cell non-Hodgkin’s lymphomas(B-NHLs).Epidemiological and molecular st...Hepatitis C virus(HCV)and hepatitis B virus(HBV)infections are increasingly recognized as significant etiological factors in the pathogenesis of B-cell non-Hodgkin’s lymphomas(B-NHLs).Epidemiological and molecular studies have demonstrated a consistent association between chronic viral infection and B-NHLs.Multiple pathogenic mechanisms have been implicated in lymphomagenesis,both direct and indirect,including chronic antigenic stimulation,direct infection of B cells,and viral protein-mediated oncogenic signaling,It is likely that a combination of several pathogenic conditions is required to eventually lead to the development of lymphoma.The prevalence of B-cell lymphomas among individuals with chronic HCV or HBV infection presents a complex pathogenetic scenario,given the tumor heterogeneity and variable clinical behavior,and poses therapeutic challenges,due to the partial efficacy of current treatment options.The advent of direct-acting antivirals(DAAs)for HCV and high-genetic barrier nucleos(t)ide analogues(NAs)for HBV has improved patient outcomes.In indolent HCV-associated B-NHLs,antiviral therapy with DAAs alone often achieves sustained virologic response and may lead to lymphoma regression.Conversely,aggressive subtypes like diffuse large B-cell lymphomas require combination treatment with immunochemotherapy.In the setting of HBV-associated lymphomas,antiviral prophylaxis with potent NAs(e.g.,entecavir or tenofovir)is essential to prevent HBV reactivation during rituximab-containing chemotherapy regimen.The integration of antiviral and anticancer therapies has been shown to enhance survival outcomes while mitigating hepatic toxicity.A comprehensive understanding of the biological interplay between chronic viral infection and B-cell transformation is critical for optimizing diagnostic and therapeutic strategies.Aim of this viewpoint is to provide evidence that early viral detection and prompt management remain the most effective strategies to improve survival rates and to reduce treatment-related morbidity in these patients.展开更多
Hyperglycemia resulting from diabetes mellitus(DM)exacerbates osteoporosis and fractures,damaging bone regeneration due to impaired healing capacity.Stem cell therapy offers the potential for bone repair,accelerating ...Hyperglycemia resulting from diabetes mellitus(DM)exacerbates osteoporosis and fractures,damaging bone regeneration due to impaired healing capacity.Stem cell therapy offers the potential for bone repair,accelerating the healing of bone defects by introducing stem cells with osteogenic differentiation ability.Dental follicle stem cells(DFSCs)are a newly emerging type of dental stem cells that not only have the potential for multipotent differentiation but also hold easy accessibility and can stand longterm storage.However,DM-associated oxidative stress and inflammation elevate the risk of DFSCs dysfunction and apoptosis,diminishing stem cell therapy efficacy.Recent nanomaterial advances,particularly in DNA nanostructures like tetrahedral framework nucleic acids(tFNAs),have been promising candidates for modulating cellular behaviors.Accumulating experiments have shown that tFNAs’cell proliferation and migration-promoting ability and induce osteogenic differentiation of stem cells.Meanwhile,tFNAs can scavenge reactive oxygen species(ROS)and downregulate the secretion of inflammatory factors by inhibiting various inflammation-related signaling pathways.Here,we applied tFNAs to modify DFSCs and observed enhanced osteogenic differentiation alongside ROS scavenging and anti-inflammatory effects mediated by suppressing the ROS/mitogen-activated protein kinases(MAPKs)/nuclear factor kappa-B(NF-κB)signaling pathway.This intervention reduced stem cell apoptosis,bolstering stem cell therapy efficacy in DM.Our study establishes a simple yet potent tFNAs-DFSCs system,offering potential as a bone repair agent for future DM treatment.展开更多
Cooperative coupling of photocatalytic hydrogen peroxide production with organic pollutants degradation has an expansive perspective in energy storage and environmental conservation.Herein,an S-scheme het-erojunction ...Cooperative coupling of photocatalytic hydrogen peroxide production with organic pollutants degradation has an expansive perspective in energy storage and environmental conservation.Herein,an S-scheme het-erojunction is constructed by hybridizing a 3D flower like Schiff-based covalent organic framework(COF)with a porous structure g-C_(3)N_(4),and a comprehensive strategy is proposed to achieve efficient H_(2)O_(2)pro-duction yield coupling highly Rhodamine B(RhB)degradation rate.The charge carrier transfer mechanism is validated by an in-situ X-ray photoelectron spectroscopy,the density functional theory calculation,and a femtosecond transient absorption spectroscopy.Interestingly,the COF/g-C_(3)N_(4)S-scheme heterojunction exhibits better charge separation efficiency compared to bare COF and pure g-C_(3)N_(4),resulting in ameliora-tive photocatalytic activity.In addition,RhB is employed to consume photogenerated holes.Remarkably,2307μmol g^(-1)h^(-1)H_(2)O_(2)achieved over 10%-COF/g-C_(3)N_(4)composite in RhB solution and O_(2)atmosphere,and 100%-RhB degradation rate obtained at 45 min.This work improves a facile strategy to ameliorate SchiffCOF-based S-scheme heterojunction for efficient H_(2)O_(2)production with full hole-electron utilization ability.展开更多
目的探析脑梗死患者髓鞘碱性蛋白(myelin basic protein,MBP)、S100钙结合蛋白B(S100 calcium-binding protein B,S100-B)水平与介入治疗后早期神经功能恶化的关联性。方法纳入2021年7月–2024年7月期间本院收治的258例脑梗死患者,采用...目的探析脑梗死患者髓鞘碱性蛋白(myelin basic protein,MBP)、S100钙结合蛋白B(S100 calcium-binding protein B,S100-B)水平与介入治疗后早期神经功能恶化的关联性。方法纳入2021年7月–2024年7月期间本院收治的258例脑梗死患者,采用美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分评估患者的神经功能状况,将死亡患者或介入治疗24 h后NIHSS评分增加4分及以上患者纳入早期神经功能恶化组,其余患者纳入未恶化组。测定所有患者MBP、S100-B水平,并分析其水平变化与介入治疗后神经功能恶化风险的关系。结果脑梗死患者早期神经功能恶化组血清MBP、S100-B水平高于未恶化组〔t=9.062(95%CI:2.348~3.663)、7.708(95%CI:0.221~0.375),P<0.001〕;Spearman相关性显示:恶化组血清MBP、S100-B水平与NIHSS评分增加情况呈正相关〔r=0.323(95%CI:0.095~0.542)、0.292(95%CI:0.066~0.488),P<0.05〕;分层回归分析显示:血清MBP〔比值比(odds ratio,OR)=1.996,95%CI:1.607~2.478〕、S100-B(OR=1.005,95%CI:1.003~1.007)水平是影响脑梗死患者早期神经功能恶化的危险因素(P<0.05),即使校正混杂因素后依然是其危险因素,此外入院NIHSS评分(OR=1.224,95%CI:1.142~1.310)及合并高血压(OR=2.542,95%CI:1.139~5.669)、高脂血症(OR=2.618,95%CI:1.101~6.228),其中入院NIHSS评分与MBP存在交互作用(OR=1.081,95%CI:1.034~1.130);受试者工作特征曲线显示:血清MBP、S100-B水平评估脑梗死患者早期神经功能恶化的曲线下面积分别为0.822(95%CI:0.764~0.879)、0.788(95%CI:0.724~0.853)。结论脑梗死患者介入治疗后血清MBP、S100-B水平较高与早期神经功能恶化风险相关,且对神经功能恶化风险有一定的评估价值。展开更多
文摘This paper deeply studies the intelligent Home embedded system based on B/S architecture. Firstly, analysis requirement of Home function based on the existing software development mode, and proposed a system framework of intelligent Home system, and designed the communication scheme of the whole Home system, also gives the system each function module realization. This paper achieve two basic service system based on Intelligent Home through a series of analysis and design： outdoor remote intelligent Home monitoring service and the indoor intelligent management service.
基金supported by the National Italian Research Council(CNR)“Progetto DSB.AD007.305.001”to Monica Rinaldi。
文摘Hepatitis C virus(HCV)and hepatitis B virus(HBV)infections are increasingly recognized as significant etiological factors in the pathogenesis of B-cell non-Hodgkin’s lymphomas(B-NHLs).Epidemiological and molecular studies have demonstrated a consistent association between chronic viral infection and B-NHLs.Multiple pathogenic mechanisms have been implicated in lymphomagenesis,both direct and indirect,including chronic antigenic stimulation,direct infection of B cells,and viral protein-mediated oncogenic signaling,It is likely that a combination of several pathogenic conditions is required to eventually lead to the development of lymphoma.The prevalence of B-cell lymphomas among individuals with chronic HCV or HBV infection presents a complex pathogenetic scenario,given the tumor heterogeneity and variable clinical behavior,and poses therapeutic challenges,due to the partial efficacy of current treatment options.The advent of direct-acting antivirals(DAAs)for HCV and high-genetic barrier nucleos(t)ide analogues(NAs)for HBV has improved patient outcomes.In indolent HCV-associated B-NHLs,antiviral therapy with DAAs alone often achieves sustained virologic response and may lead to lymphoma regression.Conversely,aggressive subtypes like diffuse large B-cell lymphomas require combination treatment with immunochemotherapy.In the setting of HBV-associated lymphomas,antiviral prophylaxis with potent NAs(e.g.,entecavir or tenofovir)is essential to prevent HBV reactivation during rituximab-containing chemotherapy regimen.The integration of antiviral and anticancer therapies has been shown to enhance survival outcomes while mitigating hepatic toxicity.A comprehensive understanding of the biological interplay between chronic viral infection and B-cell transformation is critical for optimizing diagnostic and therapeutic strategies.Aim of this viewpoint is to provide evidence that early viral detection and prompt management remain the most effective strategies to improve survival rates and to reduce treatment-related morbidity in these patients.
基金supported by the National Natural Science Foundation of China (Nos. 82101077, 82370929)Sichuan Science and Technology Program (Nos. 2023NSFSC1516, 2023NSFSC1706)+3 种基金Postdoctoral Science Foundation of China (Nos. 2021M692271, 2023T160455, BX20220220, 2022M722251)West China School/Hospital of Stomatology Sichuan University (No. RCDWJS2023–5)Fundamental Research Funds for the Central UniversitiesResearch and Develop Program, West China Hospital of Stomatology Sichuan University
文摘Hyperglycemia resulting from diabetes mellitus(DM)exacerbates osteoporosis and fractures,damaging bone regeneration due to impaired healing capacity.Stem cell therapy offers the potential for bone repair,accelerating the healing of bone defects by introducing stem cells with osteogenic differentiation ability.Dental follicle stem cells(DFSCs)are a newly emerging type of dental stem cells that not only have the potential for multipotent differentiation but also hold easy accessibility and can stand longterm storage.However,DM-associated oxidative stress and inflammation elevate the risk of DFSCs dysfunction and apoptosis,diminishing stem cell therapy efficacy.Recent nanomaterial advances,particularly in DNA nanostructures like tetrahedral framework nucleic acids(tFNAs),have been promising candidates for modulating cellular behaviors.Accumulating experiments have shown that tFNAs’cell proliferation and migration-promoting ability and induce osteogenic differentiation of stem cells.Meanwhile,tFNAs can scavenge reactive oxygen species(ROS)and downregulate the secretion of inflammatory factors by inhibiting various inflammation-related signaling pathways.Here,we applied tFNAs to modify DFSCs and observed enhanced osteogenic differentiation alongside ROS scavenging and anti-inflammatory effects mediated by suppressing the ROS/mitogen-activated protein kinases(MAPKs)/nuclear factor kappa-B(NF-κB)signaling pathway.This intervention reduced stem cell apoptosis,bolstering stem cell therapy efficacy in DM.Our study establishes a simple yet potent tFNAs-DFSCs system,offering potential as a bone repair agent for future DM treatment.
基金supported by the National Natural Science Foundation of China(Nos.22409128,22378103,and 52202376)the China Postdoctoral Science Foundation(No.2022TQ0316).
文摘Cooperative coupling of photocatalytic hydrogen peroxide production with organic pollutants degradation has an expansive perspective in energy storage and environmental conservation.Herein,an S-scheme het-erojunction is constructed by hybridizing a 3D flower like Schiff-based covalent organic framework(COF)with a porous structure g-C_(3)N_(4),and a comprehensive strategy is proposed to achieve efficient H_(2)O_(2)pro-duction yield coupling highly Rhodamine B(RhB)degradation rate.The charge carrier transfer mechanism is validated by an in-situ X-ray photoelectron spectroscopy,the density functional theory calculation,and a femtosecond transient absorption spectroscopy.Interestingly,the COF/g-C_(3)N_(4)S-scheme heterojunction exhibits better charge separation efficiency compared to bare COF and pure g-C_(3)N_(4),resulting in ameliora-tive photocatalytic activity.In addition,RhB is employed to consume photogenerated holes.Remarkably,2307μmol g^(-1)h^(-1)H_(2)O_(2)achieved over 10%-COF/g-C_(3)N_(4)composite in RhB solution and O_(2)atmosphere,and 100%-RhB degradation rate obtained at 45 min.This work improves a facile strategy to ameliorate SchiffCOF-based S-scheme heterojunction for efficient H_(2)O_(2)production with full hole-electron utilization ability.
文摘目的探析脑梗死患者髓鞘碱性蛋白(myelin basic protein,MBP)、S100钙结合蛋白B(S100 calcium-binding protein B,S100-B)水平与介入治疗后早期神经功能恶化的关联性。方法纳入2021年7月–2024年7月期间本院收治的258例脑梗死患者,采用美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分评估患者的神经功能状况,将死亡患者或介入治疗24 h后NIHSS评分增加4分及以上患者纳入早期神经功能恶化组,其余患者纳入未恶化组。测定所有患者MBP、S100-B水平,并分析其水平变化与介入治疗后神经功能恶化风险的关系。结果脑梗死患者早期神经功能恶化组血清MBP、S100-B水平高于未恶化组〔t=9.062(95%CI:2.348~3.663)、7.708(95%CI:0.221~0.375),P<0.001〕;Spearman相关性显示:恶化组血清MBP、S100-B水平与NIHSS评分增加情况呈正相关〔r=0.323(95%CI:0.095~0.542)、0.292(95%CI:0.066~0.488),P<0.05〕;分层回归分析显示:血清MBP〔比值比(odds ratio,OR)=1.996,95%CI:1.607~2.478〕、S100-B(OR=1.005,95%CI:1.003~1.007)水平是影响脑梗死患者早期神经功能恶化的危险因素(P<0.05),即使校正混杂因素后依然是其危险因素,此外入院NIHSS评分(OR=1.224,95%CI:1.142~1.310)及合并高血压(OR=2.542,95%CI:1.139~5.669)、高脂血症(OR=2.618,95%CI:1.101~6.228),其中入院NIHSS评分与MBP存在交互作用(OR=1.081,95%CI:1.034~1.130);受试者工作特征曲线显示:血清MBP、S100-B水平评估脑梗死患者早期神经功能恶化的曲线下面积分别为0.822(95%CI:0.764~0.879)、0.788(95%CI:0.724~0.853)。结论脑梗死患者介入治疗后血清MBP、S100-B水平较高与早期神经功能恶化风险相关,且对神经功能恶化风险有一定的评估价值。
